STUDY POPULATION. A total of 161 children aged 4 to 12 years, 95 with asthma and 66 without asthma, were recruited from within a study of 193 children being studied for the effects of rhinovirus infection on asthma.
REVIEWER COMMENTS. Influenza infection is more likely to cause chest symptoms in a child with underlying asthma, but in addition, this study suggests that children with asthma also become infected at a higher rate. This increased susceptibility to infection appeared to be unique to influenza virus as opposed to rhinovirus and other viruses. Whereas the mechanism of this increased susceptibility to infection with a particular virus needs to be explored, infection with the particular virus involved (influenza) can often be prevented by vaccination. METHODS. Five asthma-associated 17q21 single-nucleotide polymorphisms (SNPs) were genotyped in the COAST cohort. Each SNP was evaluated for an association with the development of asthma, as well as HRV or RSV wheezing illness, by using a logistic regression model or a linear regression model. The authors also evaluated for interactions between the specific 17q21 genotypes and HRV or RSV wheezing illness as it pertains to the development of asthma. Last, this study examined genotype-specific expression of 17q21 genes in unstimulated and HRV-stimulated PBMCs by using the blood samples obtained from each adult volunteer.
RESULTS. The 17q21 variants identified in the COAST cohort were associated with HRV wheezing illness in early life, but not with RSV wheezing illness. The association of 17q21 variants and the development of asthma was seen only in children who also had been ill with HRV wheezing illnesses, suggesting a significant interaction effect between the 17q21 variant and HRV in early life. The expression of 2 of the 17q21 genes, ORMDL3 and GSDMB, was significantly increased in HRV-stimulated PBMCs compared with unstimulated PBMCs.
CONCLUSIONS. This study revealed that the association between 17q21 genotypes and asthma is restricted to only those who also had HRV wheezing illness in early childhood. There is a significant interaction between 17q21 genotypes and HRV wheezing illness in early life with respect to childhood-onset asthma.
REVIEWER COMMENTS. This study helps reinforce the idea that the pathogenesis of asthma involves complex interactions between genetic factors and environmental triggers. Whereas this report does not establish whether risk of asthma is correlated directly to wheezing illness (as both could be related to an underlying genetic susceptibility in a subgroup of this 17q21 genotype), it certainly underscores the importance of additional studies to better understand both the roles and potential interdependence of genetic factors and illness events early in life with regard to asthma risk. Because exacerbations are most likely an important influence in perpetuating asthma, this mechanism could shed some light on why some children are at higher risk of persistent asthma, whereas, in others, asthma is more likely to remit. RESULTS. Higher exposure to ozone and carbon monoxide was associated with airway hyperresponsiveness at the time of enrollment. Previous episodes of bronchiolitis increased the child's risk of both current wheezing and physician-diagnosed asthma. When the 2 factors were combined, the risk of airway hyperresponsiveness, wheezing, physician-diagnosed asthma, and decreased pulmonary function test results was higher.
CONCLUSIONS. In children, those who had both a history of bronchiolitis and exposure to higher amounts of air pollution were found to have a higher prevalence of asthma, heightened bronchial reactivity, and decreased lung function compared with children without these exposures.
REVIEWER COMMENTS. This study is novel in that it is the first to reveal an apparently synergistic effect between bronchiolitis and air pollution on the development of asthma in children. Further research is needed into the mechanisms of this synergy, as well as possible targets for intervention, to prevent the development of asthma in this high-risk population. A total of 253 subjects were originally recruited at age 1 month.
METHODS. Maximal flow at functional residual capacity (VmaxFRC) was measured in 1-month-old infants who were then followed up at ages 6, 12, and 18 years. On the basis of symptoms reported, the subjects were categorized as having remittent wheeze (wheezing at earlier assessments but not at age 18 years), later-onset wheeze (wheezing at age 18 years but not earlier), persistent wheeze (wheezing at age 18 years and at least 1 earlier assessment), or no wheeze. Smoking status was also noted at age 18 years.
RESULTS. Of the subjects originally recruited, 150 were followed up at age 18 years. Thirty-seven of them had recent wheeze. Compared with the no-wheeze group (n 5 96), persistent wheeze (n 5 13) was independently associated with a reduced percentage of predicted VmaxFRC (mean reduction: 43%; 95% confidence interval [CI]: 13%-74%). Compared with the no-wheeze group, persistent wheeze was also associated with atopy in infancy (odds ratio [OR]: 7.1; 95% CI: 1.5-34.5), maternal asthma (OR: 6.8; 95% CI: 1.4-32.3), and active smoking (OR: 4.8; 95% CI: 1.0-21.3). When only wheeze at age 18 years was considered, a reduced percentage of predicted VmaxFRC was associated with wheeze at age 18 years only among current smokers (P 5 .04).
CONCLUSIONS. Persistent wheezing is associated with multiple factors, including reduced lung function at age 1 month, infant-onset atopy, maternal asthma, and active smoking. Wheeze at age 18 years, regardless of previous wheeze status, is associated with active smoking but only among those with reduced lung function in infancy.
